These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6390194)

  • 21. [Treatment of acute alcoholic hepatitis with prednisolone. 45 patients].
    Bories P; Guedj JY; Mirouze D; Yousfi A; Michel H
    Presse Med; 1987 May; 16(16):769-72. PubMed ID: 2954078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
    Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
    J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis.
    Hallé P; Paré P; Kaptein E; Kanel G; Redeker AG; Reynolds TB
    Gastroenterology; 1982 May; 82(5 Pt 1):925-31. PubMed ID: 7037524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition.
    Mendenhall CL; Tosch T; Weesner RE; Garcia-Pont P; Goldberg SJ; Kiernan T; Seeff LB; Sorell M; Tamburro C; Zetterman R
    Am J Clin Nutr; 1986 Feb; 43(2):213-8. PubMed ID: 3080866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
    Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
    Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.
    Lin SM; Sheen IS; Chien RN; Chu CM; Liaw YF
    Hepatology; 1999 Mar; 29(3):971-5. PubMed ID: 10051505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.
    Mathurin P; Abdelnour M; Ramond MJ; Carbonell N; Fartoux L; Serfaty L; Valla D; Poupon R; Chaput JC; Naveau S
    Hepatology; 2003 Dec; 38(6):1363-9. PubMed ID: 14647046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
    Trinchet JC; Beaugrand M; Callard P; Hartmann DJ; Gotheil C; Nusgens BV; Lapiere CM; Ferrier JP
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):551-5. PubMed ID: 2753302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
    Mathurin P; Louvet A; Duhamel A; Nahon P; Carbonell N; Boursier J; Anty R; Diaz E; Thabut D; Moirand R; Lebrec D; Moreno C; Talbodec N; Paupard T; Naveau S; Silvain C; Pageaux GP; Sobesky R; Canva-Delcambre V; Dharancy S; Salleron J; Dao T
    JAMA; 2013 Sep; 310(10):1033-41. PubMed ID: 24026598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is therapy with testosterone or anabolic-androgenic steroids useful in the treatment of alcoholic liver disease?
    Maddrey WC
    Hepatology; 1986; 6(5):1033-5. PubMed ID: 3530942
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term treatment of alcoholic liver disease with propylthiouracil.
    Orrego H; Blake JE; Blendis LM; Compton KV; Israel Y
    N Engl J Med; 1987 Dec; 317(23):1421-7. PubMed ID: 3317042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with an anabolic agent is associated with improvement in respiratory function in persons with tetraplegia: a pilot study.
    Spungen AM; Grimm DR; Strakhan M; Pizzolato PM; Bauman WA
    Mt Sinai J Med; 1999 May; 66(3):201-5. PubMed ID: 10377553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroids in the management of alcoholic hepatitis.
    Wrona SA; Tankanow RM
    Am J Hosp Pharm; 1994 Feb; 51(3):347-53. PubMed ID: 8160686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial.
    Mezey E; Caballería J; Mitchell MC; Parés A; Herlong HF; Rodés J
    Hepatology; 1991 Dec; 14(6):1090-6. PubMed ID: 1959859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroids in chronic B-hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. A trial group of the European Association for the Study of the Liver.
    Liver; 1986 Aug; 6(4):227-32. PubMed ID: 2877383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
    Wells JT; Said A; Agni R; Tome S; Hughes S; Dureja P; Lucey MR
    Liver Transpl; 2007 Dec; 13(12):1728-35. PubMed ID: 18044757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis.
    Duvoux C; Radier C; Roudot-Thoraval F; Maille F; Anglade MC; Van Nhieu JT; Rosa I; Hospitel S; Abd-Alsamad I; Sitruk V; Seror O; Ziol M; Blondon H; Dhumeaux D; Richardet JP
    Hepatology; 2004 Dec; 40(6):1370-8. PubMed ID: 15565651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.